Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...

Please provide your email address to receive an email when new articles are posted on . The FDA Orthopaedic and Rehabilitation Devices Panel voted 5-0 Tuesday to recommend approving the premarket ...

Synvisc-One (hylan G-F 20, from Genzyme), has been FDAapproved for the relief of pain associated with osteoarthritis (OA) of the kneein patients who have failed to respond adequately to ...

Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...

Biotechnology company Genzyme said Tuesday that U.S. regulators requested additional analyses and data related to its application to have Synvisc-One approved to treat knee pain from osteoarthritis.

BOSTON, Feb 26 (Reuters) - Genzyme Corp said on Thursday it has won European approval to make its drug Myozyme at a 4,000-liter manufacturing facility, expanding supply for patients with the rare ...

Hylan G-F 20 (hylan A and hylan B) 48mg; per 6mL; soln for intra-articular inj. Avian protein, feathers, or egg allergy. Severely inflamed knee joints. Lymphatic or venous stasis in leg. Advise ...

What Are Hyalgan and Synvisc? Hyaluronic acid is a natural, gel-like substance in your joints. It cushions and lubricates your joints as you move them. If you develop OA, cartilage in your joint ...

To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...

Important Therapy Provides Six Months Pain Relief with Single Injection Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...